Albupoietin…New protein available for surgery. Useful?


Albupoietin™ is a protein derived from a direct fusion of the gene for human erythropoietin (EPO) and the gene for human serum albumin. The fusion produces a single polypeptide that combines the therapeutic activity of erythropoietin (EPO) with the long half-life characteristics of human serum albumin. Albupoietin™ has demonstrated activity in numerous in vitro and in vivo models with data suggesting an enhanced PK/PD profile relative to other long acting EPO products presently on the market. A completed investigational new drug package is available for Albupoietin.

Deja un comentario

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *